Hot Results
Quick Search
Large-scale studies
- Genome-wide Association Studies of ADHD
- Genome-wide Linkage Studies of ADHD
- Genome-wide CNV Analyses of ADHD
- Meta-analysis Studies of ADHD
Data Summary
Study Report
Reference | Domene S, 201121184580 |
---|---|
Citation | Domene S., Stanescu H., Wallis D., Tinloy B., Pineda D. E., Kleta R., Arcos-Burgos M., Roessler E. and Muenke M. (2011) "Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility." Am J Med Genet B Neuropsychiatr Genet, 156B(1): 11-8. |
Study Design | case-control |
Study Type | Mutational study |
Sample Size | 139 cases, 52 controls |
Predominant Ethnicity |
Summary | In this study, they identified LPHN3, a novel ADHD susceptibility gene harbored in 4q, and showed that a LPHN3 common haplotype confers susceptibility to ADHD and predicts effectiveness of stimulant medication. They presented the mutational analysis of the entire coding region of LPHN3 in a cohort of 139 ADHD subjects and 52 controls from across the USA. They identified 21 variants, of which 14 have been reported and 7 are novel. These include 5 missense, 8 synonymous, and 8 intronic changes. Interestingly, neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations, suggesting that non-coding variations determining the quantity and/or quality of LPHN3 isoforms are the likely contributors to this common behavioral disorder. |
---|---|
Total Sample | A total of 139 unrelated patients diagnosed with ADHD and 52 commercially available normal controls not screened for ADHD were studied. |
Diagnosis Description | based on DSMIVR criteria; see Palacio et al., 2004; Acosta et al., 2008; Arcos- Burgos et al., 2010 |
Technique | Genomic DNA was extracted from peripheral blood or transformed lymphoblast cell lines by standard methods. Mutation detection was performed by PCR-based denaturing high performance liquid chromatograhy (dHPLC) analysis followed by direct sequencing. PCR amplification, dHPLC analysis WAVE(TM) and WAVEMAKER(TM) (Transgenomic, Omaha, NE), amplicon purification Qiagen PCR purification kit (Qiagen, Valencia, CA), and DNA sequencing Big Dye(TM) version 3.1 terminator cycle sequencing on an ABI 3100 (Applied Biosystems, Foster City, CA) instrument were performed according to the manufacturers instructions, essentially as previously described [Schimmenti et al., 2003]. dHPLC has a sensitivity and specificity of over 96% [Xiao and Oefner, 2001]. For this study we used the reference sequence NT_022778.15 from NCBI to determine which exons to examine. |
Analysis Method | They annotated LPHN3 using the UCSC Genome Browser custom track capabilities.They included information derived fromdatabases (such as expression information on mRNAs, ESTs, spliced ESTs from NCBI, UCSC, and EMBL; miRNA genes from AceView; miRNA binding sites from UCSC; variation information from dbSNP; domains and motifs from SwissPro, interPro, Pfam, and ProDom). They then placed the variants in their biological context within their annotation and analyzed if they fell in the following: predicted domains, motifs, glycosylation and/or phosphorylation sites, splice sites (donor, branch point, acceptor), splice site regulators (AG nucleotide Exclusion Zones: AGEZ; Exonic Splice-site Enhancers using ESEfinder 2.0) [Cartegni et al., 2003b], predicted 30UTR regulatory elements (including miRNAs, miRNA binding sites) and conserved short sequence-stretches: Exact Plus [Antonellis et al., 2006], Vista [Frazer et al., 2004]. Swissprot Q9HAR2 was used as the reference sequence for variant nomenclature. They performed signal peptide search using Signal P3.0 [Bendtsen et al., 2004], EUnited Kingdomaryotic Linear Motif (ELM) analysis [Puntervoll et al., 2003] and a Kyte-Doolittle/Hopp-Woods hydropathy plot-as implemented in the Molecular Toolkit/Protein Hydrophobicity Plots (www.vivo.colostate.edu/molkit). |
Result Description | Twenty-four exons, including all intron-exon boundaries, were screened for heterozygous mutations in the USA population sample of ADHD patients and normal controls using dHPLC. In total, we detected 21 variants out of which 14 have been reported (dbSNP build 130) and 7 are novel. These include 5 missense, 8 synonymous, and 8 intronic changes. Interestingly, neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations, suggesting that non-coding variations determining the quantity and/or quality of LPHN3 isoforms are the likely contributors to this common behavioral disorder. |
SNP | Allele Change | Risk Allele | Statistical Values | Author Comments | Result of Statistical Analysis |
---|---|---|---|---|---|
rs10434219 | c.612C>T | ObsHET/PredHET=0.374/0.401 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs10013832 | c.1977G>A | ND | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs12648576 | c.1869+20G>A | ND | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs12509110 | c.2782C>G | ND | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs1397548 | c.2811A>G | ObsHET/PredHET=0.466/0.456 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs1397547 | c.2709G>C | ObsHET/PredHET=0.177/0.168 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs2305339 | c.1908-4G>A | ObsHET/PredHET=0.462/0.429 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs2172802 | c.269+51A>G | ND | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs34586911 | c.180G>A | ObsHET/PredHET=0.251/0.252 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs34246405 | c.2322T>C | ObsHET/PredHET=2/178 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs734644 | c.2079T>C | ObsHET/PredHET=0.459/0.427 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs56038622 | c.3032-45A>T | ObsHET/PredHET=0.006/0.008 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs9312082 | c.1195+17G>A | Obs/PredHET=0.374/0.401 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend | |
rs73823293 | c.3191+31G>A | ObsHET/PredHET=0.308/0.314 | neither susceptibility nor protective haplotype alleles are ...... neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations More... | Trend |
Variant Name | Allele Change | Risk Allele | Statistical Values | Author Comments | Result of Statistical Analysis |
---|---|---|---|---|---|
LPHN3 2348C>T | c.2348C>T | ObsHET/PredHET=0.324/0.353 ObsHET/PredHET=0.324/0.353 | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend | |
LPHN3 3387+36A>G | c.3387+36A>G | ObsHET/PredHET=1/167 ObsHET/PredHET=1/167 | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend | |
LPHN3 471G>A | c.471G>A | ObsHET/PredHET=0.478/0.473 ObsHET/PredHET=0.478/0.473 | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend | |
LPHN3 1670G>A | c.1670G>A | ND ND | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend | |
LPHN3 839G>T | c.839G>T | ND ND | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend | |
LPHN3 1869-13T>C | c.1869-13T>C | ObsHET/PredHET=176/176 ObsHET/PredHET=176/176 | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend | |
LPHN3 1394G>A | c.1394G>A | ObsHET/PredHET=0.177/0.168 ObsHET/PredHET=0.177/0.168 | neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations | Trend |
Gene | Statistical Values/Author Comments | Result of Statistical Analysis |
---|---|---|
LPHN3 | 21 variants were identified, of which 14 have been reported ...... 21 variants were identified, of which 14 have been reported and 7 are novel. These include 5 missense, 8 synonymous, and 8 intronic changes. a LPHN3 common haplotype confers susceptibility to ADHD and predicts effectiveness of stimulant medication. More... | Trend |
Copyright: Bioinformatics Lab, Institute of Psychology, Chinese Academy of Sciences Feedback
Last update: Feb 26, 2014